B.pharm. Camile Semighini Grubor

Camile Semighini Grubor has extensive work experience in the pharmaceutical and medical writing fields. Camile currently holds the position of VP Portfolio Director & Team Lead at Envision Pharma Group, where they lead a team and manages various publications accounts. Prior to this role, they served as a Senior Scientific Director & Team Lead, responsible for a portfolio focused on immunotherapy for multiple myeloma. Camile also held the position of Scientific Director & Team Lead, overseeing scientific direction and strategy for account-related activities.

Before joining Envision Pharma Group, Camile founded and served as the Principal of InnoCreating Consulting, LLC, where they specialized in assisting clients with technical communication and problem-solving. Camile also worked as a Freelance Medical Writer and Consultant, gaining experience in medical writing and consulting roles.

Camile's earlier experience includes working as a Licensing Analyst Intern at North Carolina State University, where they evaluated new technologies and collaborated with inventors and Licensing Associates. Camile was also an Intellectual Property Informational Scientist at BASF, where they conducted patent searches and managed information flow for regulatory purposes. Additionally, they worked as a Technical Grant Writer at Advanced Liquid Logic, contributing to the development of proposals and product concepts.

Camile's academic background includes a Ph.D. in Pharmaceutical Sciences, and they have held research positions as a Post-Doctoral Associate at Duke University and as a Post-Doctoral Fellow at Cold Spring Harbor Laboratory. Camile began their research career as an Exchange Visitor Research Assistant at the University of Nebraska-Lincoln.

Camile Semighini Grubor, B.Pharm., Ph.D. began their education in 1996 at USP - Universidade de São Paulo, where they earned their Bachelor of Pharmacy (B.Pharm) degree in Pharmacy and Biochemistry, specializing in Clinical and Toxicological Analyses, in the year 2000. Following this, they pursued a Master of Science (MSc) degree in Molecular and Cell Biology at USP from 2001 to 2003.

In 2004, Camile Semighini Grubor enrolled at the University of Nebraska-Lincoln, where they completed their Doctor of Philosophy (PhD) degree in Biological Sciences, with a minor in Plant Pathology, in 2007.